Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel DiseasesErwin Dreesen, Séverine Vermeire, Bram Verstockt et al.|Clinical Gastroenterology and Hepatology|2018Cited by 158
Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UCKathleen Machiels, Séverine Vermeire, Kristel Van Steen et al.|Gut|2015Cited by 140
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s DiseaseThomas Billiet, Séverine Vermeire, Konstantinos Papamichael et al.|Journal of Crohn s and Colitis|2015Cited by 71
Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?Manuel Noben, Marc Ferrante, Bram Verstockt et al.|Gut|2017Cited by 56
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn’s disease patients?Bram Verstockt, Marc Ferrante, Sare Verstockt et al.|Gut|2018Cited by 54